Register
Login:
Share:
Email Facebook Twitter

London South East Natural Resources Briefing webcast: #Emmerson #Alba #Condor Gold #Gold analysis Watch Now

London South East Natural Resources Briefing webcast: #Emmerson #Alba #Condor Gold #Gold analysis
Angus Energy in talks to buy 'transformational' gas asset in North England


ShareCast News


Indivior surges as directors buy up shares

Wed, 15th May 2019 14:15


(Sharecast News) - Indivior shares got a boost on Wednesday as the drug developer revealed that some of its directors had been buying up the stock.

The company, which makes opioid addiction treatment Suboxone, said chief executive officer Sean Thaxter bought 100,000 shares at 44.64p each, leaving him with an interest of just over 1.6 million shares.

Meanwhile, non-executive director Daniel Phelan bought 10,000 ADRs, representing 50,000 shares at an average price of $2.78 each, leaving him with an interest in 60,318 Shares.

Tatjana May, another non-executive director, bought 22,309 shares at 44.58p each, leaving her with 22,309 shares.

Indivior has come under pressure recently after it was hit with US fraud charges over a marketing scheme used to boost prescriptions of its opioid addiction drugs.

At 1425 BST, the shares were up 11.7% at 50.55p.


Related Shares:



Back to ShareCast News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.